现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
30期
3313-3314,3317
,共3页
周怡萍%韩宏斌%梁宁震%房修椢
週怡萍%韓宏斌%樑寧震%房脩椢
주이평%한굉빈%량저진%방수귀
结肠癌%化疗%热化疗%CD4 +CD25 +T细胞%CTL细胞
結腸癌%化療%熱化療%CD4 +CD25 +T細胞%CTL細胞
결장암%화료%열화료%CD4 +CD25 +T세포%CTL세포
colon cancer%chemotherapy%thermochemotherapy%CD4 +CD25 +regulatory T cells%cytotoxic T cell
目的:探讨结肠癌患者化疗/热化疗前后CD4+CD25+T细胞和CTL的变化及临床意义。方法选取68例结肠癌患者,分为化疗组34例和热化疗组34例,患者治疗前后采用流式细胞术检测外周血淋巴细胞中CD4+CD25+T细胞的表达,同时检测患者CTL细胞的功能,对比观察2组患者的检测结果,分析和探讨结肠癌患者化疗/热化疗前后 CD4+CD25+T细胞和CTL的变化及临床意义。结果化疗组患者治疗前后CD4+CD25+T细胞水平分别为(19±9)和(19±3),无显著性差异(P>0.05);热化疗组患者治疗前后分别为(20±7)和(15±8),有显著性差异( P<0.05);热化疗组患者治疗后的CD4+CD25+T细胞水平明显低于化疗组(P<0.05)。 CTL细胞杀伤活性化疗组患者治疗前后分别为(10.4±2.2)和(15.1±4.4),热化疗组患者治疗前后分别为(10.9±2.7)和(17.5±3.8),2组比较治疗前后比较均有显著性差异(P均<0.05);热化疗组患者治疗后的CTL细胞杀伤活性显著优于化疗组(P<0.05)。结论热化疗可明显改善结肠癌患者的免疫抑制状态,增强患者CTL细胞的杀伤活性,可提高患者的临床治疗效果,改善预后,值得临床推广应用。
目的:探討結腸癌患者化療/熱化療前後CD4+CD25+T細胞和CTL的變化及臨床意義。方法選取68例結腸癌患者,分為化療組34例和熱化療組34例,患者治療前後採用流式細胞術檢測外週血淋巴細胞中CD4+CD25+T細胞的錶達,同時檢測患者CTL細胞的功能,對比觀察2組患者的檢測結果,分析和探討結腸癌患者化療/熱化療前後 CD4+CD25+T細胞和CTL的變化及臨床意義。結果化療組患者治療前後CD4+CD25+T細胞水平分彆為(19±9)和(19±3),無顯著性差異(P>0.05);熱化療組患者治療前後分彆為(20±7)和(15±8),有顯著性差異( P<0.05);熱化療組患者治療後的CD4+CD25+T細胞水平明顯低于化療組(P<0.05)。 CTL細胞殺傷活性化療組患者治療前後分彆為(10.4±2.2)和(15.1±4.4),熱化療組患者治療前後分彆為(10.9±2.7)和(17.5±3.8),2組比較治療前後比較均有顯著性差異(P均<0.05);熱化療組患者治療後的CTL細胞殺傷活性顯著優于化療組(P<0.05)。結論熱化療可明顯改善結腸癌患者的免疫抑製狀態,增彊患者CTL細胞的殺傷活性,可提高患者的臨床治療效果,改善預後,值得臨床推廣應用。
목적:탐토결장암환자화료/열화료전후CD4+CD25+T세포화CTL적변화급림상의의。방법선취68례결장암환자,분위화료조34례화열화료조34례,환자치료전후채용류식세포술검측외주혈림파세포중CD4+CD25+T세포적표체,동시검측환자CTL세포적공능,대비관찰2조환자적검측결과,분석화탐토결장암환자화료/열화료전후 CD4+CD25+T세포화CTL적변화급림상의의。결과화료조환자치료전후CD4+CD25+T세포수평분별위(19±9)화(19±3),무현저성차이(P>0.05);열화료조환자치료전후분별위(20±7)화(15±8),유현저성차이( P<0.05);열화료조환자치료후적CD4+CD25+T세포수평명현저우화료조(P<0.05)。 CTL세포살상활성화료조환자치료전후분별위(10.4±2.2)화(15.1±4.4),열화료조환자치료전후분별위(10.9±2.7)화(17.5±3.8),2조비교치료전후비교균유현저성차이(P균<0.05);열화료조환자치료후적CTL세포살상활성현저우우화료조(P<0.05)。결론열화료가명현개선결장암환자적면역억제상태,증강환자CTL세포적살상활성,가제고환자적림상치료효과,개선예후,치득림상추엄응용。
Objective It is to investigate the changes and clinical significance of CD 4 +CD25 +regulatory T cells? and cy-totoxic T cell in patients with colon cancer treated by chemotherapy or thermochemotherapy .Methods 68 patients with colon cancer were collected and divided into chemotherapy group with 34 cases and thermochemotherapy group with 34 cases, CD4 +CD25 +regulatory T cells in peripheral blood before and after treatment were measured by flow cytometry , and the killing func-tion of cytotoxic T cell was detected at the same time .The test results of two groups were compared , and the changes and clini-cal significance of CD 4+CD25 +regulatory T cells and cytotoxic T cell in patients with colon cancer treated by chemotherapy or thermochemotherapy were analyzed and discussed .Resul ts The level of CD4 +CD25 +regulatory T cells , chemotherapy group before and after treatment respectively was 19 ±9 and 19 ±3, there was no significant difference (P>0.05).Thermochemo-therapy group before and after treatment respectively was 20 ±7 and 15 ±8, There was significant difference(P<0.05).The change of CD4 +CD25 +regulatory T cells after treatment of thermochemotherapy group was significantly lower than chemothera -py group (P<0.05).The killing function of cytotoxic T cell, chemotherapy group before and after treatment respectively was 10.4 ±2.2 and 15.1 ±4.4, thermochemotherapy group respectively was 10.9 ±2.7 and 17.5 ±3.8, there was no significant difference between them in both groups (P<0.05).The change of killing function of cytotoxic T cell after treatment of ther-mochemotherapy group was significantly better than chemotherapy group , (P<0.05).Conclusion Thermochemotherapy can significantly improve the status of immunesuppression in colon cancer patients and enhance killing function of cytotoxic T cell , and can improve the clinical effect and the prognosis , it is worth to be widely applied clinically .